CaMK II

CaMKII is a Ca2+/calmodulin-dependent serine/threonine kinase that converts intracellular calcium signals into phosphorylation-dependent cellular responses[1]. In excitatory synapses, CaMKII is central to synaptic plasticity, learning, and memory, where it phosphorylates synaptic proteins that regulate receptor trafficking, localization, activity, actin dynamics, translation, and transcription[1]. Mechanistically, Ca2+/calmodulin binding activates the regulatory domain, and CaMKII tools now support studies across cell types and cellular functions[2]. In disease-relevant models, CaMKIIδ expression increases in human heart failure, and CaMKII inhibition acutely improves contractility by reducing sarcoplasmic-reticulum Ca2+ leak and increasing Ca2+ load[3]. Compared with related isoforms, CaMKIIα and CaMKIIβ are largely brain-specific, whereas CaMKIIγ and CaMKIIδ show broader tissue expression[4]. The α and β isoforms mediate synaptic functions underlying learning, memory, and cognition, but CaMKIIβ has high-affinity F-actin binding that distinguishes it from CaMKIIα[4]. Structural comparison of α, β, γ, and δ isoforms documented shared holoenzyme architecture with measurable enzymatic differences among gene products[5]. For experimental applications, KN-93 inhibits CaMKII activity by binding Ca2+/calmodulin, supporting its use as a mechanistic inhibitor with target-engagement considerations[6].